ChemoCentryx Inc

NASDAQ:CCXI   9:43:03 AM EDT
54.11
+0.11 (+0.20%)
Earnings Announcements

ChemoCentryx Posts Quarterly Loss Per Share $0.35

Published: 11/09/2020 22:32 GMT
ChemoCentryx Inc (CCXI) - Chemocentryx Reports Third Quarter 2020 Financial Results and Recent Highlights.
Q3 Revenue $5.1 Million Versus $10.6 Million.
Q3 Revenue Estimate $10.7 Million -- Refinitiv Ibes Data (analyst estimates).
Qtrly Loss per Share $0.35.
Revenue is expected to be $8.52 Million
Adjusted EPS is expected to be -$0.33

Next Quarter Revenue Guidance is expected to be $5.73 Million
Next Quarter EPS Guidance is expected to be -$0.40

More details on our Analysts Page.